- Alm J J, Heino T J, Hentunen T A, Väänänen H K, Aro H T. Transient 100 nM dexamethasone treatment reduces inter- and intraindividual variations in osteoblastic differentiation of bone-marrow derived human mesenchymal stem cells. Tissue Engineering Part C 2012; 18: 658–66.
- Balena R, Toolan B C, Shea M, Markatos A, Myers E R, Lee S C, Opas E E, Seedor J G, Klein H, Frankenfield D. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest 1993; 92: 2577–86.
- Bellido T, Plotkin L I. Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability. Bone 2011; 49: 50–5.
- Bonnarens F, Einhorn T A. Production of a standard closed fracture in laboratory animal bone. J Orthop Res 1984; 2: 97–101.
- Boyce R W, Paddock C L, Gleason J R, Sletsema W K, Eriksen E F. The effects of risedronate on canine cancellous bone remodeling: three-dimensional kinetic reconstruction of the remodeling site. J Bone Miner Res 1995; 10: 211–21.
- Bravenboer N, Papapoulos SE, Holzmann P, Hamdy N A, Netelenbos J C, Lips P. Bone histomorphometric evaluation of pamidronate treatment in clinically manifest osteoporosis. Osteoporos Int 1999; 9: 489–93.
- Chavassieux P M, Arlot M E, Reda C, Wei L, Yates A J, Meunier P J. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest 1997; 100: 1475–80.
- Fleisch H. Development of bisphosphonates. Breast Cancer Res 2000; 4: 30–4.
- Fromigué O, Body J J. Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts. J Endocrinol Invest 2002; 25: 539–46.
- Giuliani N, Pedrazzoni M, Negri G, Passeri G, Impicciatore M, Girasole G. Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo. Bone 1998; 22: 455–61.
- Gourion-Arsiquaud S, Allen M R, Burr D B, Vashishth D, Tang S Y, Boskey A L. Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone 2010; 46: 666–72.
- Heino T J, Hentunen T A, Väänänen H K. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts. Exp Cell Res 2004; 294: 458–68.
- Hiltunen A, Vuorio E, Aro H T. A standardized experimental fracture in the mouse tibia. J Orthop Res 1993; 11: 305–12.
- Im G I, Qureshi S A, Kenney J, Rubash H E, Shanbhag A S. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 2004; 25: 4105–15.
- Li J, Mori S, Kaji Y, Mashiba T, Kawanishi J, Norimatsu H. Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats. J Bone Miner Res 1999; 14: 969–79.
- Li J, Mori S, Kaji Y, Kawanishi J, Akiyama T, Norimatsu H. Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats. J Bone Miner Res 2000; 15: 2042–51.
- Maruotti N, Corrado A, Neve A, Cantatore F P. Bisphosphonates: effects on osteoblast. Eur J Clin Pharmacol; 68: 1013–8.
- McDonald M M, Dulai S, Godfrey C, Amanat N, Sztynda T, Little D G. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling. Bone 2008; 43: 653–62.
- Pan B, To L B, Farrugia A N, Findlay D M, Green J, Gronthos S, Evdokiou A, Lynch K, Atkins GJ, Zannettino A C. The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. Bone 2004; 34: 112–23.
- Recker R R, Delmas P D, Halse J, Reid I R, Boonen S, Garcia-Hernandez P A, Supronik J, Lewiecki E M, Ochoa L, Miller P, Hu H, Mesenbrink P, Hartl F, Gasser J, Eriksen E F. Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res 2008; 23: 6–16.
- Reinholz G G, Getz B, Pederson L, Sanders E S, Subramaniam M, Ingle J N, Spelsberg T C. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res 2000; 60: 6001–7.
- Rogers M J. New insights into the molecular mechanisms of action of bisphosphonates. Curr Pharm Des 2003; 9: 2643–58.
- Salmon P L. Bone micro-CT analysis. A short guide to analysis of bone by micro-CT. SkyScan, Kontich, Belgium 2005.
- Storm T, Steiniche T, Thamsborg G, Melsen F. Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis. J Bone Miner Res 1993; 8: 199–208.
- Szulc P. The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis. Clin Biochem 2012; 45: 907–19.
- Välimäki V V, Moritz N, Yrjans J J, Vuorio E, Aro H T. Effect of zoledronic acid on incorporation of a bioceramic bone graft substitute. Bone 2006; 38: 432–43.
- Zhou S, LeBoff M S, Glowacki J. Vitamin D metabolism and action in human bone marrow stromal cells. Endocrinology 2010; 151: 14–22.
- Choose new content alerts to be informed about new research of interest to you
- Easy remote access to your institution's subscriptions on any device, from any location
- Save your searches and schedule alerts to send you new results
- Export your search results into a .csv file to support your research